pentobarbital will reduce the level or effect of nateglinide by impacting hepatic enzyme CYP2C9/ten metabolism. Use Caution/Monitor.
pentobarbital will reduce the extent or outcome of alosetron by affecting hepatic enzyme CYP2C9/10 metabolism. Insignificant/Importance Not known.
Monitor Closely (1)pentobarbital will minimize the extent or result of levamlodipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lessen the extent or impact of fludrocortisone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
Barbiturates could cause fetal harm when administered to the Expecting lady; retrospective, case-managed scientific tests have advised a connection concerning maternal use of barbiturates and a better-than-expected incidence of fetal abnormalities
Check Closely (two)pentobarbital will lessen the level or result of oliceridine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. If coadministration having a CYP3A4 inducer is necessary, take into account expanding oliceridine dose until steady drug outcomes are obtained; monitor for signs of opioid withdrawal.
pentobarbital will reduce the extent or effect of capivasertib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. read more Stay clear of or Use Alternate Drug. Powerful or reasonable CYP3A inducers minimize capivasertib exposure, which can reduce efficacy.
Prescription drugs which have quantity limits connected to Every single prescription. This restriction generally limitations the amount of your drug that could be coated.
pentobarbital will decrease the extent or effect of sildenafil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Powerful CYP3A4 inducers are expected to cause considerable decreases in sildenafil plasma ranges
pentobarbital and daridorexant both of those raise sedation. Modify Therapy/Monitor Closely. Coadministration increases risk of CNS depression, which can lead to additive impairment of psychomotor effectiveness and result in daytime impairment.
Contraindicated (1)pentobarbital will lessen the extent or impact of doravirine by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lower the extent or influence of dexamethasone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will lessen the level or influence of clarithromycin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unfamiliar.
pentobarbital will decrease the level or result of finasteride by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unknown.